Saturday, April 20, 2024
September 14 - 18, 2015; Stockholm, Sweden
Visit Medscape in Hall B Booth #B13:31
EASD
Metformin Intolerance Increased by Genes, Other Meds
EASD
Assisted Reproduction Ups Risk of Gestational Diabetes
EASD
Better Gut Microbiota Shift With Bypass vs Sleeve Gastrectomy
EASD
Cognitive Deficits Linked to Hypo Awareness in Type 1 Diabetes
EASD
Data Support Twice Yearly Exenatide 'Minipump' for Diabetes
EASD
Insulin Pumps Help Some Type 2 Diabetes Patients for 5 Years
EASD
Pesticides Linked to Increased Risk of Diabetes
EASD
Metformin Link to Vitamin B12 Deficiency, Neuropathy in Diabetes
EASD
Twin Study: Environment Affects Inhibition of Food Intake
EASD
After EMPA-REG: Docs Dissect Diabetes Study, Discuss Implications
EASD
No Yard, 'Disadvantaged' Neighborhood, Up Child Obesity
EASD
First Data on SGLT2 Inhibitor Canagliflozin in Type 1 Diabetes
Alert EASD
Capsaicin Patch Approved in EU for Diabetic Neuropathy Pain
EASD
Home Use of 'Artificial Beta Cell' Works for 3 Months
EASD
Toddler May Be Youngest Ever Diagnosed With Type 2 Diabetes
EASD
Diabetes Drug Cuts CV Deaths in Landmark EMPA-REG Trial
EASD
Hyperbaric-Oxygen Therapy: Better Survival at 6 Years
EASD
Postprandial Hyperglycemia Interferes With Work Productivity
EASD
Poor Glycemic Control Associated With Dementia in Diabetes
EASD
Study Suggests Incretin Drugs Don't Cause Pancreatic Cancer
EASD
Intranasal Glucagon Promising for Severe Hypoglycemia
EASD
EMPA-REG OUTCOME Results Top EASD Agenda in Stockholm
Medscape Diabetes© WebMD, LLC
Debate: Do We Need Triple and Quadruple Therapies in Diabetes?
Minimizing DKA Risk With SGLT2 Inhibitors in Type 1 Diabetes
The Psychosocial Factors of the Obesity Epidemic: 3 S's
How Dangerous Is Fructose?
Type 2 Diabetes Management: Choosing the Best Therapies
Behind the Scenes at EASD 2015
Cognitive Impairments in Elderly Diabetic Patients: Understanding the Risks for Better Management
Understanding the Phenotypes of Prediabetes to Prevent Type 2 Diabetes
EMPA-REG: Insights From a Lead Investigator
